AGTR1 and Hypertension: Increased JAK2 activity was associated with angiotensin II type 1 receptor-mediated hypertension and other cardiovascular diseases [112,113], JAK2 is activated in various myeloproliferative disorders [114,115], and JAK2 is overexpressed in polycystic kidney disease [116].